Some big things happening at Mannatech

Some big things happening at Mannatech

MTEX Performance – Top NASDAQ gainer on November 7

According to Yahoo finance, Mannatech stocks (listed as MTEX) were amongst the 10 biggest percentage gainers on Nasdaq at the close of trading on November 7 2014.

Rob Sinnott, CEO and Chief Science Officer at Mannatech, commented: “…congratulations…[to] Mannatech [for being] the top gaining stock (64.1%) on the NASDAQ index yesterday based on solid third quarter earnings. It’s all about focus and execution.  There is no magic to this we just need to strive to be a little better every day.”

What a result!

Mannatech announced healthy financial results for its third quarter ended September 30, 2014 last week.

Third quarter net sales 2014 for Mannatech were USD$55.6 million, an increase of 25.2% as compared to USD$44.4 million in the third quarter of 2013. Hit “Like” to show your support of these healthy sales results!

Mannatech’s net sales for Q3 2014 increased 22.5% in constant dollars. Dr. Rob Sinnott, CEO and CSO, commented, “The growth in net sales reflects the continued expansion of our business, the recent launch of our Uth skin care product in markets outside of North America, and the anniversary of our loyalty program.”

 

For the three months ended September 30, 2014, Mannatech’s operations outside of North America accounted for approximately 63.4% of consolidated net sales, whereas in the same period in 2013, operations outside of North America accounted for approximately 57.8% of consolidated net sales.

For the three months ended September 30, 2014, Asia/Pacific net sales increased by USD$8.3 million, or 37.7%, to USd$30.3 million, as compared to USD$22.0 million for the same period in 2013 primarily because of growth in the number of active associates and growth in the revenue per active associate and member. The Asia/Pacific region comprises Australia, New Zealand, Japan, Taiwan, Singapore, the Republic of Korea, and Hong Kong).

Source: Seeking Alpha, November 4

 

Mannatech Launches  A New Advanced Immune Support Product

What comes in individual slimstick packets for convenient, on-the-go support for healthy immune function?

On Friday 7th November 2014, Mannatech launched a new advanced immune support product called GlycoBOOM slimsticks. This product is the 32nd addition to the currently active line of products in the United States. For now, GlycoBOOM slimsticks are only available in the U.S.

 

GlycoBOOM slimsticks are a new dietary supplement based on Mannatech’s exclusive Manapol® powder that features a proprietary herbal and glyconutrient blend with plant and food-sourced vitamin C. GlycoBOOM slimsticks are also free of gluten, dairy, soy and synthetics and contains no artificial flavours, colours or sweeteners.

Naturally, Mannatech Australasian Associates are asking the big question…when will GlycoBOOM slimsticks hit our shores in Australasia? Stay tuned…sometime in 2015.

Mannatech Appoints Eric W. Schrier To Board Of Directors

On November. 3, 2014, Mannatech Incorporated announced the appointment of Eric W. Schrier to the Board of Directors, effective October 28, 2014.Stanley J. Fredrick, Chairman of the Board of Mannatech, Incorporated, commented, “Mr. Schrier brings a wealth of valuable experience in digital and print media, customer acquisition, and direct selling.”

Mr. Schrier, age 62, has held a number of senior executive positions plus more recently, board roles:

  • President and CEO, The Reader’s Digest Association January 2006 to March 2007.
  • Chairman, Board of Directors for Edible Media, a multi-platform media company in the farm-to-table food space (current).
  • Serves on the Boards of Directors for TEN (The Enthusiast Network), American Chemical Society , Reader’s Digest Association  and MeQuilibrium.
  • He has previously served on the boards of Willow House, Demdex Corp  and Bonnier USA .
  • Since January 2009, he has consulted with large media corporations to help them create and pursue their digital strategies and diversify their revenue streams.

Mannatech Antioxidant Product Receives Two New Patents

On October 15 2014, Mannatech announced the issuance of two new patents pertaining to its Ambrotose AO formulations, increasing the total patents held by the company to 98.

Mannatech received the Certificate of Grant from both the Indian and Australian Patent Offices for their Ambrotose AO formulation pertaining to the Methods and Compositions for Modified Release of Nutritional Supplements. The Australian patent was issued on September 18, 2014. Both patents will remain in effect for 20 years from the date of filing.

There are currently 33 patents issued worldwide to Mannatech for the technology pertaining to this formula. Overall, 98 patents have been issued worldwide to Mannatech for the technology pertaining to its Ambrotose®, Ambrotose AO, GI-ProBalance®, and PhytoMatrix® product formulations and in the field of biomarker assays.

“The vast majority of antioxidant supplements rely on high-dose synthetic ingredients,” said Dr. Rob Sinnott, CEO and Chief Science Officer at Mannatech. “We knew when we launched Ambrotose AO back in 2003 that a better approach would be to formulate a synergistic blend of fat- and water-soluble food-sourced antioxidant nutrients that resemble the nutrients found in a diet rich in fresh fruits and vegetables.”

“Proof of the benefit of Ambrotose AO supplementation, as measured by increased serum oxygen radical antioxidant capacity (ORAC), has been confirmed in three human clinical trials,”[1][2][3]continued Dr. Sinnott. “The product’s safety has been confirmed during these studies and by 11 years of data collected by our outstanding Safety Monitoring Program.”[4]

 

Events around Australasia

There are plenty of opportunities to find out more about Mannatech and its products, learn how to expand your Mannatech business or simply listen to interesting speakers on a range of topics close to Mannatech’s core philosophy. Why are attending events so important to your business? Events play a role in your personal and professional development as the owner of a Mannatech business. Events have this magical way of helping all of us believe we can succeed with a Mannatech business. Events show us more than any video, book or CD ever could. Yes those things are important, however attending events is like being fully immersed in the things required to succeed. CLICK HERE to listen to South African Presidential Director Kirsten Pearse explain just how important attending meetings and events are to building a successful Mannatech nutrition business.

 

When you run any type of event or meeting, be sure to take a few photos and videos to capture the excitement. We would love to publish your photos/videos and your 100 word write-up in our next REALlife and on Facebook. Just email marketing@mannatech.com.au.

Would you like us to advertise your event? Please contact marketing@mannatech.com.au

Click here for a complete list of events around Australasia.

Narrogin – Regional opportunity

Orange – Business presentation

Albany – Training weekend

Saturday Morning Call – travelling world wide to support, train and inspire Associates

Gold Coast – Team Training

Singapore – Meeting and Training

Orange – Health and Nutrition

Adelaide – Training Session

Gold Coast – Opportunity Meeting

Christchurch – Opportunity Meeting

 

© 2014 Mannatech, Incorporated. All rights reserved.

Mannatech, Ambrotose AO, Stylised M Design, M5M and Mission 5 Million are trademarks of Mannatech, Incorporated.

 

[1] Boyd S, Gary K, Koepke CM, et al. An open-label pilot study of the antioxidant effect in healthy people of Ambrotose AO. GlycoScience & Nutrition 2003; 4(6): 1-6.

[2] Myers SP, Stevenson L, Cheras PA, et al. A forced titration study of the antioxidant and immunomodulatory effects of Ambrotose AO supplement. BMC Comp Alt Med 2010; 10(16): 1-16.

[3] Bloomer RJ, Canale RE, Blankenship MM, et al. Effect of Ambrotose AO on resting and exercise-induced antioxidant capacity and oxidative stress in healthy adults. Nutr J 2010; 9(49): 1-17.

[4] None of the statements made by Dr Sinnott have been evaluated by the Therapeutic Goods Administration. Ambrotose AO is not intended to diagnose, treat, cure, or prevent any disease.

 

Next Post:
Previous Post:

Leave a Reply

Your email address will not be published. Required fields are marked *